CRISPR-Cas-Based Genome Editing for Treating Human Diseases - Part B: Volume 210 (Progress in Molecular Biology and Translational Science, Volume 210) - Image 1

£110.59

Academic Press CRISPR-Cas-Based Genome Editing for Treating Human Diseases - Part B: Volume 210 (Progress in Molecular Biology and Translational Science, Volume 210)

Name: CRISPR-Cas-Based Genome Editing for Treating Human Diseases - Part B: Volume 210 (Progress in Molecular Biology and Translational Science, Volume 210)
Brand: Academic Press
Price: 110.59 GBP
Availability: InStock

Biochemistry

New to our records — first sighting 24 days ago. We'll learn its rhythm.

24 days of data · current price £111

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 1 days · 1 data points (no recent data)

Historical

Generating forecast…

Not enough data points to display chart (need at least 2 points)

Price Distribution

Price distribution over 1 days • 1 price levels

Days at Price

Price Analysis

Most common price: £111 (1 days, 100.0%)

Price range: £111 - £111

Price levels: 1 different prices over 1 days

Description

CRISPR-Cas-Based Genome Editing for Treating Human Diseases, Part B represents CRISPR-Cas systems for genome editing. Currently, CRISPR-Cas systems have been proven to be a key technology for targeted genome editing, which is acting as a simple, rapid, and cost-effective solution. Chapters in this release include Current approaches in CRISPR –Cas systems for metabolic disorders, Recent progress in CRISPR –Cas systems for CRISPR for retinal diseases, Recent progress in CRISPR –Cas systems for cataract and blindness, Advances in CRISPR –Cas systems for muscular dystrophy, Recent development in CRISPR –Cas systems for cardiac disease, Current approaches in CRISPR –Cas systems for diabetes, and much more. Additional sections cover Advances in CRISPR –Cas systems for liver disease, Advances in CRISPR –Cas systems for lung disease, Advances in CRISPR –Cas systems for kidney diseases, Current progress in CRISPR –Cas systems for rare disease, Advances in CRISPR –Cas systems for heredity disease, Recent progress in CRISPR –Cas systems for neurological disorders, and CRISPR challenges in clinical developments. Provides CRISPR-Cas systems for metabolic disorders, retinal disease cataracts, and blindness Offer updates on muscular dystrophy, cardiac disease, diabetes, and liver disease Includes content on lung disease, kidney diseases, rare diseases, heredity diseases, neurological disorders, and CRISPR challenges in clinical developments

Product Specifications

Brand: Academic Press
Format: hardcover
ASIN: 044322420X
Category: Books > Subjects > Science, Nature & Maths > Biological Sciences > Biochemistry
Domain: Amazon UK
Release Date: 01 January 2025
Listed Since: 22 May 2024

Barcode

No barcode data available

Academic Press CRISPR-Cas-Based Genome Editing for Treating Human Diseases - Part B: Volume 210 (Progress in Molecular Biology and Translational Science, Volume 210)

New to our records — first sighting 24 days ago. We'll learn its rhythm.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

CRISPR-Cas-Based Genome Editing for Treating Human Diseases-Part A: Volume 208 (Progress in Molecular Biology and Translational Science, Volume 208)

CRISPR-Cas Systems for RNA and Genome Editing (Volume 712) (Methods in Enzymology, Volume 712)

CRISPR-Cas9 as a Revolutionary Gene Editing Tool: Genome Engineering, Advances and Applications in Agriculture

CRISPR Technologies - Advances in Genome Editing, Applications, and Ethical Implications (Genetics)

CRISPR-Cas Methods: Volume 3 (Springer Protocols Handbooks)

Epigenetics and Cancer, Part B: 71 (Advances in Genetics): Volume 71

Epigenetics in Health and Disease: Volume 197 (Progress in Molecular Biology and Translational Science, Volume 197)

Academic Press - Targeted Genome Engineering via CRISPR/Cas9 in Plants

Epigenetic Regulation of Cancer - Part E: Volume 400 (International Review of Cell and Molecular Biology, Volume 400)

Design and Applications of Cell-Free Systems Part B: Volume 219 (Progress in Molecular Biology and Translational Science, Volume 219)

Artificial Intelligence for Genetic Manipulation With Python: Causal Models, Generative Design, and Uncertainty for CRISPR, Proteins, and Regulatory Control (Computational Mathematics Library)

Artificial Intelligence for Genetic Manipulation With Python: Causal Models, Generative Design, and Uncertainty for CRISPR, Proteins, and Regulatory Control (Computational Mathematics Library)

Epigenome Editing: Methods and Protocols (Methods in Molecular Biology, 2842)

Principles of Computational Biology and Genome Analysis

Epigenetic Regulation of Cancer - Part B: Volume 383 (International Review of Cell and Molecular Biology, Volume 383)

CRISPR-Cas Methods (Springer Protocols Handbooks)

CRISPR-Cas Methods (Springer Protocols Handbooks)

Non-coding RNA: Volume 214 (Progress in Molecular Biology and Translational Science, Volume 214)

Cosmic Genetic Evolution: Volume 106 (Advances in Genetics, Volume 106)

Epigenetic Regulation of Cancer - Part A (Volume 380) (International Review of Cell and Molecular Biology, Volume 380)

Genome Editing Tools and Gene Drives: A Brief Overview (Pocket Guides to Biomedical Sciences)

Grand Celebration: 10th Anniversary of the Human Genome Project: Volume 3

Epigenetic Regulation of Cancer - Part D: Volume 390 (International Review of Cell and Molecular Biology, Volume 390)

Governance of Human Gene Editing and Transhumanism: Tasks for Today’s Bioethics: 28 (Integrated Science, 28)